Retrograde mechanico-chemical endovenous ablation of infrageniculate great saphenous vein for persistent venous stasis ulcers

Phlebology. 2014 Dec;29(10):654-7. doi: 10.1177/0268355513501301. Epub 2013 Aug 22.

Abstract

Objective: To present the use of retrograde mechanico-chemical endovenous ablation for ablating the remaining below-knee great saphenous vein in patients with venous stasis ulcers persisting after above-knee great saphenous vein ablation.

Methods: This small study includes six patients with persistent C6EpAsPr ulcers following above-knee great saphenous vein ablation with no incompetent perforators. They were treated using retrograde mechanico-chemical endovenous ablation approach followed by Unna therapy, followed up on post op days 3 and 30 with ultrasound, and subsequent weekly visits until the wound healed.

Results: Six patients (four men and two women), have average ulcer size of 4.1 cm(2). There was no nerve injury or other complications after mechanico-chemical endovenous ablation. These patients had an average of 28 ± 11 days healing time, compared with a mean of five months in traditional method.

Conclusion: Mechanico-chemical endovenous ablation can be safe and effective in the treatment of patients with below-knee great saphenous vein insufficiency with venous ulcers.

Keywords: Retrograde mechanico-chemical endovenous ablation; ablation of great saphenous vein; infrageniculate great saphenous vein ablation; modified mechanico-chemical endovenous ablation; venous stasis ulcers.

Publication types

  • Clinical Trial

MeSH terms

  • Catheter Ablation / methods*
  • Combined Modality Therapy
  • Debridement
  • Endovascular Procedures / methods*
  • Female
  • Humans
  • Male
  • Saphenous Vein / diagnostic imaging
  • Saphenous Vein / surgery*
  • Sclerosing Solutions / administration & dosage
  • Sclerotherapy / methods*
  • Skin, Artificial
  • Stockings, Compression
  • Ultrasonography
  • Varicose Ulcer / diagnostic imaging
  • Varicose Ulcer / surgery
  • Varicose Ulcer / therapy*
  • Wound Healing

Substances

  • Sclerosing Solutions